Showing results (31-40 of 209) with videos related to
Sort By:
Pageof 21
Molecular Cell|September 4, 2018
Quantitative Activity Profile and Context Dependence of All Human 5' Splice SitesMandy S Wong, Justin B Kinney, Adrian R KrainerCell Reports|May 1, 2012
Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYCShipra Das, Olga Anczuków, Martin Akerman, et al.RNA (New York, N.Y.)|December 21, 2011
Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2Shuying Sun, Zuo Zhang, Oliver Fregoso, et al.Annual Review of Neuroscience|July 9, 2019
Antisense Oligonucleotide Therapies for Neurodegenerative DiseasesC Frank Bennett, Adrian R Krainer, Don W ClevelandBMC Molecular Biology|January 20, 2007
Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOBBernard Khoo, Xavier Roca, Shern L Chew, et al.Plos One|September 6, 2007
Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicingStephanie D Shaw, Sutapa Chakrabarti, Gourisankar Ghosh, et al.Biorxiv : the Preprint Server for Biology|April 10, 2026
Exon-Skipping Antisense Oligonucleotides for H3.3K27M-Altered Diffuse Midline Glioma TherapyLucia Yang, Qian Zhang, John E Wilkinson, et al.The Journal of Cell Biology|October 3, 2012
Antisense-based therapy for the treatment of spinal muscular atrophyFrank Rigo, Yimin Hua, Adrian R Krainer, et al.Nature Biotechnology|December 15, 2015
Antisense oligonucleotide-directed inhibition of nonsense-mediated mRNA decayTomoki T Nomakuchi, Frank Rigo, Isabel Aznarez, et al.Molecular Cell|March 13, 2013
Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescenceOliver I Fregoso, Shipra Das, Martin Akerman, et al.Pageof 21